Tenecteplase Beyond the 4.5-h Window for Patients with Acute Ischemic Stroke: An Updated Meta-Analysis of Randomized Controlled Trials.

Gonçalves OR, Scarcia L, Portela JGS, Santos GSB, Cardoso LJC, da Silva AMP, de Melo Neto AP, Sanders JV, Falcão L, de Bastos Maximiano ML, Porto LFVN, Clarençon F, Nguyen T, Almeida KJ, Günkan A

Open source

DOI
10.1007/s40263-026-01308-6
Published
2026 Aug
Container
CNS drugs
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40263-026-01308-6,
  title = {Tenecteplase Beyond the 4.5-h Window for Patients with Acute Ischemic Stroke: An Updated Meta-Analysis of Randomized Controlled Trials.},
  author = {Gonçalves OR and Scarcia L and Portela JGS and Santos GSB and Cardoso LJC and da Silva AMP and de Melo Neto AP and Sanders JV and Falcão L and de Bastos Maximiano ML and Porto LFVN and Clarençon F and Nguyen T and Almeida KJ and Günkan A},
  year = {2026},
  journal = {CNS drugs},
  doi = {10.1007/s40263-026-01308-6},
  url = {https://doi.org/10.1007/s40263-026-01308-6}
}

RIS

TY  - JOUR
TI  - Tenecteplase Beyond the 4.5-h Window for Patients with Acute Ischemic Stroke: An Updated Meta-Analysis of Randomized Controlled Trials.
AU  - Gonçalves OR
AU  - Scarcia L
AU  - Portela JGS
AU  - Santos GSB
AU  - Cardoso LJC
AU  - da Silva AMP
AU  - de Melo Neto AP
AU  - Sanders JV
AU  - Falcão L
AU  - de Bastos Maximiano ML
AU  - Porto LFVN
AU  - Clarençon F
AU  - Nguyen T
AU  - Almeida KJ
AU  - Günkan A
PY  - 2026
JO  - CNS drugs
DO  - 10.1007/s40263-026-01308-6
UR  - https://doi.org/10.1007/s40263-026-01308-6
ER  - 

APA

OR, G., L, S., JGS, P., GSB, S., LJC, C., AMP, D. S., AP, D. M. N., JV, S., L, F., ML, D. B. M., LFVN, P., F, C., T, N., KJ, A., & A, G. (2026). Tenecteplase Beyond the 4.5-h Window for Patients with Acute Ischemic Stroke: An Updated Meta-Analysis of Randomized Controlled Trials.. CNS drugs. https://doi.org/10.1007/s40263-026-01308-6

Source records